Clinical experience with U-500 regular insulin in obese, markedly insulin-resistant type 2 diabetic patients.
Ballani
Piya
P
Clinical Center for Research Excellence, Charles R. Drew University, 1731 E. 120th St., Los Angeles, CA 90059, USA.
Tran
Michael T
MT
Navar
Maria D
MD
Davidson
Mayer B
MB
D000328:Adult; D000465:Algorithms; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D007328:Insulin / Q000008:administration & dosage*; D007333:Insulin Resistance; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000150:complications*; D016896:Treatment Outcome; D015430:Weight Gain / Q000187:drug effects
D007004:Hypoglycemic Agents; D007328:Insulin